2m 2m 2m 2m 2m 2m 2m
IMMUNOCORE SP ADS (IMCR)
NASDAQ
$36.92+$0.03 (+0.09%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.9BMarket Cap
- 12.00%1-Year Change
- BiotechnologyIndustry
IMMUNOCORE SP ADS (IMCR)
$36.92+$0.03 (+0.09%)
IMCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.88 | ||
Change | +$0.60 (+1.65%) | ||
Open | $36.70 | ||
High | $36.98 | ||
Low | $35.68 | ||
Previous Close | $36.28 | ||
Volume | 329,451 | ||
30-Day Average Volume | 446,291 | ||
1-Week Change | 7.80% | ||
1-Month Change | 6.96% | ||
1-Year Change | 12.00% | ||
3-Year Change | -38.39% | ||
5-Year Change | 31.81% | ||
Fundamentals | |||
Shares Outstanding | 51.5M | ||
Total Assets | $1.1B | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $115.9M | ||
Net Income | -$808,000.00 | ||
Free Cash Flow | $15.1M | ||
EBIT | $2.5M | ||
EBITDA | $3.6M | ||
Net Working Capital | $815.8M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | 506 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 5 | ||
P/E | -1,844 | ||
PEG | 17 | ||
Price/Free Cash Flow | 125 | ||
Price/Operating Cash Flow | 119 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue